Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Isabelle A. van Zeventer, Aniek O. de Graaf, Melanie M. van der Klauw, Edo Vellenga, Bert A. van der Reijden, Jan Jacob Schuringa, Arjan Diepstra, Luca Malcovati, Joop H. Jansen, Gerwin Huls

Blood Adv (2021) 5 (17): 3266–3278.

https://doi.org/10.1182/bloodadvances.2021004355

Published: 2021

Includes: Supplemental data

Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Blood Adv (2021) 5 (16): 3203–3215.

https://doi.org/10.1182/bloodadvances.2021004976

Published: 2021

Includes: Supplemental data

Journal Articles

B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations

Kathryn A. Six, Ulrike Gerdemann, Anna L. Brown, Andrew E. Place, Alan B. Cantor, Matthew A. Kutny, Serine Avagyan

Blood Adv (2021) 5 (16): 3199–3202.

https://doi.org/10.1182/bloodadvances.2021004653

Published: 2021

Journal Articles

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Blood Adv (2021) 5 (16): 3163–3173.

https://doi.org/10.1182/bloodadvances.2020003829

Published: 2021

Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz

Blood Adv (2021) 5 (13): 2794–2798.

https://doi.org/10.1182/bloodadvances.2021004957

Published: 2021

Journal Articles

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, Lilian Kolte, Daniel El Fassi, Jens Hillingsø, Aneta Radziwon-Balicka, Robert Sebastian Soyka, Klaus Hansen, Nikolai Kirkby, Jens P. Goetze, Mikkel Gybel-Brask, Eva Birgitte Leinøe, Anne-Mette Hvas, Peter Kampmann, Jakob Stensballe

Blood Adv (2021) 5 (12): 2569–2574.

https://doi.org/10.1182/bloodadvances.2021004904

Published: 2021

Journal Articles

Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis

Gulab Fatima Rani, Olivier Preham, Helen Ashwin, Najmeeyah Brown, Ian S. Hitchcock, Paul M. Kaye

Blood Adv (2021) 5 (6): 1627–1637.

https://doi.org/10.1182/bloodadvances.2020004082

Published: 2021

Includes: Supplemental data

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial

Blood Adv (2021) 5 (5): 1250–1258.

https://doi.org/10.1182/bloodadvances.2020002790

Published: 2021

Includes: Supplemental data

Journal Articles

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Noelle O'Rourke, Matthew Beasley, Wojciech Jurczak, Unn-Merete Fagerli, Michal Kaščák, Mike Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Veronique Pascal, Harald Holte

Blood Adv (2020) 4 (17): 4091–4101.

https://doi.org/10.1182/bloodadvances.2020002583

Published: 2020

Includes: Supplemental data

Journal Articles

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Monica Sacco, Stefano Lancellotti, Mattia Ferrarese, Francesco Bernardi, Mirko Pinotti, Maira Tardugno, Erica De Candia, Leonardo Di Gennaro, Maria Basso, Betti Giusti, Massimiliano Papi, Giordano Perini, Giancarlo Castaman, Raimondo De Cristofaro

Blood Adv (2020) 4 (14): 3405–3415.

https://doi.org/10.1182/bloodadvances.2020002334

Published: 2020

Includes: Supplemental data

Journal Articles

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

Vikas Gupta, Denise Wolleschak, Hans Hasselbalch, Alessandro Maria Vannucchi, Steffen Koschmieder, Francisco Cervantes, Yang Li, Tuochuan Dong, Monika Wroclawska, Savita Bharathy, Claire Harrison

Blood Adv (2020) 4 (13): 3063–3071.

https://doi.org/10.1182/bloodadvances.2019001212

Published: 2020

Includes: Supplemental data

Journal Articles

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

A. J. Gerard Jansen, Thom Spaan, Hui Zhi Low, Daniele Di Iorio, Judith van den Brand, Malte Tieke, Arjan Barendrecht, Kerstin Rohn, Geert van Amerongen, Koert Stittelaar, Wolfgang Baumgärtner, Albert Osterhaus, Thijs Kuiken, Geert-Jan Boons, Jurriaan Huskens, Marianne Boes, Coen Maas, Erhard van der Vries

Blood Adv (2020) 4 (13): 2967–2978.

https://doi.org/10.1182/bloodadvances.2020001640

Published: 2020

Journal Articles

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

Sabrina Shrestha, Ishac Nazy, James W. Smith, John G. Kelton, Donald M. Arnold

Blood Adv (2020) 4 (13): 2962–2966.

https://doi.org/10.1182/bloodadvances.2020001846

Published: 2020

Includes: Supplemental data

Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio

Blood Adv (2020) 4 (8): 1656–1669.

https://doi.org/10.1182/bloodadvances.2019001043

Published: 2020

Includes: Supplemental data

Journal Articles

Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice

Stéphane Chappaz, Charity W. Law, Mark R. Dowling, Kirstyn T. Carey, Rachael M. Lane, Linh H. Ngo, Vihandha O. Wickramasinghe, Gordon K. Smyth, Matthew E. Ritchie, Benjamin T. Kile

Blood Adv (2020) 4 (7): 1270–1283.

https://doi.org/10.1182/bloodadvances.2019001323

Published: 2020

Includes: Supplemental data

Journal Articles

Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia

Naomi Cornish, M. Riyaad Aungraheeta, Lucy FitzGibbon, Kate Burley, Dominic Alibhai, Janine Collins, Daniel Greene, Kate Downes, NIHR BioResource, Sarah K. Westbury, Ernest Turro, Andrew D. Mumford

Blood Adv (2020) 4 (5): 920–924.

https://doi.org/10.1182/bloodadvances.2019001293

Published: 2020

Includes: Supplemental data

Journal Articles

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

Blood Adv (2020) 4 (5): 858–867.

https://doi.org/10.1182/bloodadvances.2019001355

Published: 2020

Includes: Supplemental data

Journal Articles

Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model

Christian Escobar, Chen-Yuan Kao, Samik Das, Eleftherios T. Papoutsakis

Blood Adv (2020) 4 (5): 804–814.

https://doi.org/10.1182/bloodadvances.2019000753

Published: 2020

Includes: Supplemental data

Journal Articles

Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review

Yazan Migdady, Asiri Ediriwickrema, Ryan Patrick Jackson, Wendy Kadi, Ridhi Gupta, Francisco Socola, Sally Arai, Beth A. Martin

Blood Adv (2020) 4 (5): 815–818.

https://doi.org/10.1182/bloodadvances.2019001215

Published: 2020

NARROW

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in mice

Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model

Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only